
Your Feed
Filter by
See content from
Playlist: ASH 2025
Can Linvoseltamab Be Safely Combined with Anti-CD38 Antibodies? | Meletios Dimopoulos, MD
Video details & playlist
Playlist: ASH 2025
What I Learned at ASH as a Myeloma Patient: Personalized Care & Access | Valarie Traynham
Video details & playlist
Playlist: ASH 2025
Defining Functional High-Risk Myeloma & Why Its Important | Barry Paul, MD & Todd Kennedy
Video details & playlist
Playlist: ASH 2025
Join the Nutrivention 2 Study: Investigating a Plant Based Diet for MGUS or Smoldering Myeloma | Urvi Shah, MD
Video details & playlist
Playlist: ASH 2025
Highlights of Smoldering Multiple Myeloma from ASH25 | Mohamad Mohty, MD, PhD
Video details & playlist
Playlist: ASH 2025
Long-term PFS updates on the CARTITUDE-4 Trial | Luciano Costa, MD
Video details & playlist
Playlist: ASH 2025
Daratumumab VS Lenalidomide maintenance therapy in Multiple Myeloma | Urvi Shah, MD
Video details & playlist
Playlist: ASH 2025
Does Diet Impact Treatment Response? Join NUTRIVENTION Study for Newly Diagnosed Myeloma | Urvi Shah, MD
Video details & playlist




